韩国政府与私营部门利益相关者举行了协商会议，以促进人工智能（AI）在药物开发中的使用

会议将经济和财政部以及其他相关政府机构的官员与领先的制药公司一起

South Korean government officials met with private sector stakeholders on Thursday to discuss promoting the use of artificial intelligence (AI) in drug development in response to intensifying global competition in the bio-health sector, the Ministry of Economy and Finance said.

经济和金融部表示，韩国政府官员周四会见了私营部门利益相关者，讨论了促进人工智能（AI）在药物开发中的使用，以响应加强生物健康部门的全球竞争。

The meeting brought together officials from the Ministry of Economy and Finance and other relevant government agencies, alongside leading pharmaceutical companies, including Daewoong Pharmaceutical, Yonhap news agency reported.

据Yonhap新闻社报道，该会议将来自经济和财政部以及其他相关政府机构的官员与包括Daewoong Pharmaceutical在内的领先的制药公司一起。

As per the Ministry, the discussions were focused on boosting AI-based drug development and promoting effective data usage, with sessions serving as a platform to listen to challenges faced by the pharmaceutical industry and to explore directions for public-private cooperation.

根据该部的，讨论的重点是提高基于AI的药物开发并促进有效的数据使用，其会议是倾听制药行业面临的挑战的平台，并探索了公私合作的方向。

Global AI biotechnology market is projected to grow over 19 per cent annually to reach $7.75 billion by 2029. South Korea currently ranks third globally in the number of AI bio-related patent applications.

到2029年，全球AI生物技术市场预计每年将增长19％以上，达到77.5亿美元。目前，韩国在与AI Bio相关的专利申请的数量中排名全球第三。

“AI is rapidly permeating the entire biotechnology industry,” the finance ministry said. “It is emerging as a core technology across areas, such as new drug development, protein structure prediction and design, and gene therapy.”

财政部说：“ AI正在迅速渗透到整个生物技术行业。” “它正在成为跨领域的核心技术，例如新药开发，蛋白质结构预测和设计以及基因治疗。”

The ministry emphasised that countries are now in fierce competition to preemptively secure AI capabilities and apply them effectively in the bio-health field.

该部强调，国家现在处于激烈的竞争中，以先发制人的AI能力，并在生物健康领域有效地应用它们。

In particular, AI-powered drug development is revolutionizing the traditional pharmaceutical research and development process, the ministry said.

该部说，特别是AI驱动的药物开发正在彻底改变传统的制药研究和开发过程。

Meanwhile, South Korea has reported plans to funnel 60 billion won (nearly $40.4 million) by 2028 to expand infrastructure for the development of materials and components technologies essential for advanced industries, such as AI, Yonhap reported.

同时，韩国报告了计划在2028年汇入600亿韩元（近40040万美元）的计划，以扩大基础设施，以开发材料和组件技术对高级行业必不可少的材料和组件技术，例如AI，例如AI。

According to the Ministry of Trade, Industry, and Energy, the investment will be used to build research facilities and equipment for the development and testing of technologies related to materials and components essential for AI, advanced bio, and other future industries.

根据贸易，工业和能源部的说法，该投资将用于建造研究设施和设备，以开发和测试与AI，Advanced Bio和其他未来行业所必需的材料和组件相关的技术。

In detail, the government will support the construction of infrastructure for the development of core materials for next-generation AI chips, messenger RNA-based drugs, and others, the Ministry said.

该部称详细，政府将支持基础设施的建设，以开发下一代AI芯片，基于Messenger RNA的药物等核心材料。